BPC-157
Also known as: Body Protection Compound 157 · PL 14736 · Bepecin
BPC-157 upregulates growth hormone receptors in tendon fibroblasts and activates the FAK-paxillin pathway to accelerate cell migration and tissue repair. It stimulates nitric oxide synthesis via eNOS upregulation, promoting angiogenesis at injury sites. It modulates the dopaminergic and serotonergic systems,...
What It Is
BPC-157 upregulates growth hormone receptors in tendon fibroblasts and activates the FAK-paxillin pathway to accelerate cell migration and tissue repair. It stimulates nitric oxide synthesis via eNOS upregulation, promoting angiogenesis at injury sites. It modulates the dopaminergic and serotonergic systems, exerts gastroprotective effects by preserving gut mucosal integrity, and activates VEGFR2 to stimulate blood vessel formation. It also counteracts NSAID-induced mucosal damage.
Supplies Needed
Reconstitution solvent - multi-use safe due to benzyl alcohol preservative
For subcutaneous or intramuscular injection
Sterilizing vial rubber stopper and injection site skin
Safe disposal of used needles
Storage
Store at -20C for up to 2+ years. Stable at room temperature below 25C for up to 3 months if kept dry and away from light.
Refrigerate at 2-8C; use within 30 days. Do not freeze reconstituted solution.
This information is provided for educational and research purposes only. Not approved for human consumption by the FDA or any regulatory body. Always consult a qualified medical professional.
Dosing Protocols
Timing: Morning, fasted. Start low to assess tolerance; inject near injury site if targeting local repair
↓ Apply these values to the reconstitution calculatorTiming: Morning and evening, fasted. Split dose morning and evening; inject near affected tissue for local injury
↓ Apply these values to the reconstitution calculatorTiming: Morning and evening near injury site. High dose for chronic injuries; stack with TB-500 for synergistic systemic and local repair
↓ Apply these values to the reconstitution calculatorWeekly Timeline
| Week | Expected Effects |
|---|---|
| Week 1 | Reduced inflammation and pain at injury site; improved gut comfort; mild analgesic effect |
| Week 2 | Noticeable improvement in mobility and range of motion; decreased soreness; improved gut motility |
| Week 4 | Significant tissue repair progress; many users report 50-70% improvement in minor-to-moderate injuries |
| Week 8 | Full anti-inflammatory and regenerative effect; chronic injuries show substantial improvement; GI healing often complete |
Reconstitution Calculator
1 unit on U-100 syringe = 0.01 mL · Always label your vial after reconstitution
Injection Technique & Reconstitution
- Remove the plastic flip-top cap from the vial
- Wipe the rubber stopper with a fresh alcohol swab and allow to air-dry 30 seconds
- Draw 2 mL of bacteriostatic water into a syringe
- Inject the BAC water slowly down the side wall of the vial - do not spray directly onto the powder
- Gently swirl the vial until the powder is fully dissolved - do not shake
- The solution should be clear and colorless; discard if cloudy
- Label the vial with the date of reconstitution
- Store reconstituted vial in the refrigerator at 2-8 degrees C
Use our free calculate your BPC-157 dose to get the exact syringe units for your vial size and dose.
Mechanism of Action
BPC-157 upregulates growth hormone receptors in tendon fibroblasts and activates the FAK-paxillin pathway to accelerate cell migration and tissue repair. It stimulates nitric oxide synthesis via eNOS upregulation, promoting angiogenesis at injury sites. It modulates the dopaminergic and serotonergic systems, exerts gastroprotective effects by preserving gut mucosal integrity, and activates VEGFR2 to stimulate blood vessel formation. It also counteracts NSAID-induced mucosal damage.
Key Research Papers
Demonstrated significantly accelerated Achilles tendon healing in rats treated with BPC-157, with enhanced tendon cell proliferation in vitro.
View on PubMed →BPC-157 demonstrated potent gastroprotective and anti-inflammatory effects in colitis and ischemia-reperfusion injury models.
View on PubMed →Stacks Well With
Frequently Asked Questions
BPC-157 is primarily used for accelerating the healing of tendons, ligaments, muscles, and the gastrointestinal tract. It is popular among athletes for injury recovery and among individuals with gut conditions like leaky gut, IBS, or Crohn's disease.
Based on available research, BPC-157 has an excellent safety profile with no serious adverse events reported at therapeutic doses in animal or human studies. It is not FDA approved and is classified as a research chemical.
Most users report reduced pain and inflammation within 1-2 weeks. Significant tissue repair is typically noticeable by weeks 4-8, depending on injury severity.
Yes - oral BPC-157 is effective specifically for gastrointestinal conditions since it acts locally in the gut. For systemic or musculoskeletal injuries, subcutaneous injection is preferred for higher bioavailability.
Legal Status by Region
This information is provided for educational and research purposes only. Not approved for human consumption by the FDA or any regulatory body. Always consult a qualified medical professional.